Thunder’s Nikola Topić Begins Chemotherapy for Testicular Cancer
The Oklahoma City Thunder’s promising player, Nikola Topić, is now undergoing chemotherapy as he battles testicular cancer. Team president Sam Presti announced the diagnosis, emphasizing the support Topić has from a team of skilled oncologists.
Nikola Topić’s Medical Journey
Topić, selected as the No. 12 pick in the 2024 NBA Draft, is just 20 years old. He has been out of action since early in training camp due to a procedure that led to his cancer diagnosis. The biopsy results confirmed the presence of testicular cancer.
Support from Medical Professionals
- Topić is being treated by experts at Oklahoma University Hospital and MD Anderson.
- The medical team is optimistic about his prognosis, as testicular cancer is highly treatable.
- Chemotherapy has been recommended as the current treatment option.
Presti noted the importance of Topić focusing on his health during this challenging time. He stressed that the Thunder organization fully supports him, highlighting that basketball will take a backseat until Topić is ready.
Previous Performance and Future Outlook
Before his diagnosis, Topić showcased his skills during the NBA Summer League in Las Vegas and logged 31 minutes in the Thunder’s preseason opener. Although he missed the entire 2024-25 season due to a torn ACL, the team considers him integral to their future plans.
A positive aspect of Topić’s situation is his prognosis. Historical precedents exist for players returning from similar battles. Notably, Brazilian player Nene faced testicular cancer early in his career and successfully returned to play for 11 more seasons after treatment.
As Topić embarks on this journey, the Thunder community is rallying to support him during his chemotherapy treatment. The organization remains hopeful for his recovery and future contributions to the team.
